Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung syndrome, caused by long-term inhalation of noxious gases and particles, which leads to gradual airflow limitation. All health care professionals who care for COPD patients should have full access to high-quality spirometry testing, as postbronchodilator spirometry constitutes the principal method of COPD diagnosis. One out of four smokers 45 years or older presenting respiratory symptoms in primary care, have non-fully reversible airflow limitation compatible with COPD and are mostly without a known diagnosis. Approximately 50.0%-98.3% of patients are undiagnosed worldwide. The majority of undiagnosed COPD patients are isolated at home, are in nursing or senior-assisted living facilities, or are present in oncology and cardiology clinics as patients with lung cancers and coronary artery disease. At this time, the prevalence and mortality of COPD subjects is increasing, rapidly among women who are more susceptible to risk factors. Since effective management strategies are currently available for all phenotypes of COPD, correctly performed and well-interpreted postbronchodilator spirometry is still an essential component of all approaches used. Simple educational training can substantially improve physicians' knowledge relating to COPD diagnosis. Similarly, a physician inhaler education program can improve attitudes toward inhaler teaching and facilitate its implementation in routine clinical practices. Spirometry combined with inhaled technique education improves the ability of predominantly nonrespiratory physicians to correctly diagnose COPD, to adequately assess its severity, and to increase the percentage of correct COPD treatment used in a real-life setting.

Department of Pneumology University Hospital Hradec Kralove Hradec Králové Czech Republic; Faculty of Medicine in Hradec Kralove Charles University Prague Hradec Králové Czech Republic

Department of Pneumology University Hospital Hradec Kralove Hradec Králové Czech Republic; Faculty of Medicine in Hradec Kralove Charles University Prague Hradec Králové Czech Republic; Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet] Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [updated January, 2014] [Accessed September 30, 2015]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf.

Anon C. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions: a report of the conclusions of a Ciba guest symposium. Thorax. 1959;14:286–299.

Corhay JL. Personalized medicine: chronic obstructive pulmonary disease treatment. Rev Med Liege. 2015;70(5–6):310–315. PubMed

Andersson M, Stridsman C, Rönmark E, Lindberg A, Emtner M. Physical activity and fatigue in chronic obstructive pulmonary disease – a population based study. Respir Med. 2015;109(8):1048–1057. PubMed

Liu Y, Pleasants R, Croft J, et al. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2015;10:1409–1416. PubMed PMC

World Health Organisation [webpage on the Internet] Chronic Obstructive Pulmonary Disease (COPD) [updated October, 2013] [Accessed August 2, 2015]. Available from: http://www.who.int/respiratory/copd/en/

Menezes AM, Jardim JR, Pérez-Padilla R, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLA-TINO Study in Sao Paulo, Brazil. Cad Saude Publica. 2005;21(5):1565–1573. PubMed

Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457–494. PubMed PMC

Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. PubMed

Kojima S, Sakakibara H, Motani S, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol. 2007;17(2):54–60. PubMed PMC

de Marco R, Accordini S, Marcon A, et al. European Community Respiratory Health Survey (ECRHS) Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011;183(7):891–897. PubMed

Moreira GL, Gazzotti MR, Manzano BM, et al. Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study. Sao Paulo Med J. 2015;133(3):245–251. PubMed PMC

Koblizek V, Zigmond J, Pecen L, et al. Implementation of COPD Phenotypes in Real Life; Thematic Poster Session. European Respiratory Society Congress 2015; Amsterdam, the Netherlands.

Torres-Duque C, Maldonado D, Pérez-Padilla R, et al. Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008;5(5):577–590. PubMed

Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002;156(8):738–746. PubMed

Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–1154. PubMed PMC

Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50(suppl 1):1–16. PubMed

Qaseem A, Wilt TJ, Weinberger SE, et al. American College of Physicians. American College of Chest Physicians. American Thoracic Society. European Respiratory Society Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191. PubMed

Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. PubMed

Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. PubMed

Celli B, Cote C, Marin J, et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012. PubMed

Celli B. Update on the management of COPD. Chest. 2008;133:1451–1462. PubMed

O’Donnell D, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832–840. PubMed

Stridsman C, Lindberg A, Skär L. Fatigue in chronic obstructive pulmonary disease: a qualitative study of people’s experiences. Scand J Caring Sci. 2014;28:130–138. PubMed

Karpman C, Benzo R. Gait speed as a measure of functional status in COPD patients. Int J Chron Obstruct Pulmon Dis. 2014;9:1315–1320. PubMed PMC

Koblizek V, Tomsova M, Cermakova E, et al. Impairment of nasal mucociliary clearance in former smokers with stable chronic obstructive pulmonary disease relates to the presence of a chronic bronchitis phenotype. Rhinology. 2011;49:397–406. PubMed

Arikan H, Savci S, Calik-Kutukcu E, et al. The relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1829–1835. PubMed PMC

Matkovic Z, Miravitlles M. Chronic bronchial infection in COPD. Is there an infective phenotype? Respir Med. 2013;107(1):10–22. PubMed PMC

Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. PubMed

Wise RA, Anzueto A, Cotton D, et al. TIOSPIR Investigators Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med. 2013;369:1491–1501. PubMed

Cazzola M, MacNee W, Martinez FJ, et al. American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31:416–469. PubMed

Molen T, Miravitlles M, Kocks J. COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis. 2013;8:461–471. PubMed PMC

Han M, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1:43–50. PubMed PMC

Yawn B, Duvall K, Peabody J, et al. The impact of screening tools on diagnosis of chronic obstructive pulmonary disease in primary care. Am J Prev Med. 2014;47:563–575. PubMed

Jones R, Price D, Ryan D, et al. Respiratory Effectiveness Group Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2:267–276. PubMed

Lange P, Marott J, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186:975–981. PubMed

Chen CZ, Ou CY, Yu CH, Yang SC, Chang HY, Hsiue TR. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2015;63:244–250. PubMed

Sanchez-Salcedo P, Berto J, de-Torres J, et al. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP) Arch Bronconeumol. 2015;51(4):169–176. PubMed

Koblizek V, Pecen L, Zatloukal J, et al. Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatment. PLoS One. 2014;9:e111078. PubMed PMC

McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med. 2015;109:228–237. PubMed

Casanova C, Marin J, Martinez-Gonzalez C, et al. COPD History Assessment In SpaiN (CHAIN) Cohort. New GOLD classification: longitudinal data on group assignment. Respir Res. 2014;15:3. PubMed PMC

Jones P, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classification. Eur Respir J. 2013;42:647–654. PubMed

Casanova C, Marin JM, Martinez-Gonzalez C, et al. COPD History Assessment in Spain (CHAIN) Cohort Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148(1):159–168. PubMed

Koblizek V, Chlumsky J, Zindr V, et al. European Respiratory Society Congress. Amsterdam, the Netherlands: 2015. GOLD and Phenotypes: The New Czech COPD Guidelines. Thematic Poster Session.

Bakke P, Rönmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011;38:1261–1277. PubMed

Agusti A. The path to personalised medicine in COPD. Thorax. 2014;69:857–864. PubMed

Vestbo J. COPD: definition and phenotypes. Clin Chest Med. 2014;35:1–6. PubMed

Izquierdo-Alonso J, Rodriguez-Gonzálezmoro J, de Lucas-Ramos P, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD) Respir Med. 2013;107:724–731. PubMed

Miravitlles M, Calle M, Soler-Cataluña J. Clinical phenotypes of COPD. Identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48:86–98. PubMed

National Institute for Health and Care Excellence [webpage on the Internet] Chronic Obstructive Pulmonary Disease (updated) Clinical Guidelines CG101. [Accessed February 19, 2015]. Available from: http://www.nice.org.uk/CG101.

Kankaanranta H, Harju T, Kilpeläinen M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116:291–307. PubMed PMC

Gupta D, Agarwal R, Aggarwal A, et al. S. K. Jindal for the COPD Guidelines Working Group. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint ICS/NCCP (I) recommendations. Lung India. 2013;30:228–267. PubMed PMC

Khan J, Lababidi H, Al-Moamary M, et al. The Saudi guidelines for the diagnosis and management of COPD. Ann Thorac Med. 2014;9:55–76. PubMed PMC

Koblizek V, Chlumsky J, Zindr V, et al. Czech Pneumological and Phthisiological Society Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:189–201. PubMed

Soler-Cataluña J, Cosío B, Izquierdo J, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48:331–337. PubMed

Montuschi P, Malerba M, Santini G, Miravitlles M. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discov Today. 2014;19:1928–1935. PubMed

Llordés M, Jaén A, Almagro P, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD. 2015;12(4):404–412. PubMed

Lamprecht B, Soriano J, Studnicka M, et al. BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group. BOLD Collaborative Research Group the EPI-SCAN Team the PLATINO Team and the PREPOCOL Study Group Determinants of Underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. PubMed

Castillo D, Burgos F, Guayta R, et al. FARMAEPOC group Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med. 2015;109(4):475–482. PubMed

Zhang J, Zhou JB, Lin XF, Wang Q, Bai CX, Hong QY. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18(2):297–302. PubMed

Langsetmo L, Platt R, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177:396–401. PubMed

Xu W, Collet J, Shapiro S, et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J. 2010;35:1022–1030. PubMed

Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185:1218–1224. PubMed

Leidy NK, Murray LT. Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS. COPD. 2013;10:393–398. PubMed

Hunt T, Madigan S, Williams MT, Olds TS. Use of time in people with chronic obstructive pulmonary disease – a systematic review. Int J Chron Obstruct Pulmon Dis. 2014;9:1377–1388. PubMed PMC

Almagro P, Lapuente A, Yun S, et al. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:1353–1361. PubMed PMC

Jairam PM, van der Graaf Y, Lammers JW, Mali WP, de Jong PA, PROVIDI Study group Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality. Thorax. 2015;70:725–731. PubMed

Incalzi RA, Scarlata S, Pennazza G, Santonico M, Pedone C. Chronic obstructive pulmonary disease in the elderly. Eur J Intern Med. 2014;25(4):320–328. PubMed

Cai S, Qin L, Tanoue L, et al. Effects of one-hour training course and spirometry on the ability of physicians to diagnose and treat chronic obstructive pulmonary disease. PLoS One. 2015;10(2):e0117348. PubMed PMC

Schünenmann H, Woodhead M, Anzueto A, et al. ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development A guide to guidelines for professional societies and other developers of recommendations. Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):215–218. PubMed

Sarc I, Jeric T, Ziherl K, et al. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. J Eval Clin Pract. 2011;17(4):37–43. PubMed

White P, Thorton H, Pinnock H, Georgopoulou S, Booth HP. Over-treatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational study. PLoS One. 2013;8(10):e75221. PubMed PMC

Lucas A, Smeenk F, Smeele I, van Schayck C. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract. 2008;25(2):86–91. PubMed

Roche N, Pribil C, van Ganse E, et al. Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med. 2014;14(1):56. PubMed PMC

Zbozinkova Z, Barczyk A, Tkacova R, et al. POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe. Int J Chron Obstruct Pulmon Dis. 2016 PubMed PMC

Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L. Enhancing COPD management in primary care settings. MedGenMed. 2007;9(3):24. PubMed PMC

Peabody J, Luck J, DeMaria L, Menon R. Quality of care and health status in Ukraine. BMC Health Serv Res. 2014;14:446. PubMed PMC

Laube B, Janssens H, de Jongh F, et al. European Respiratory Society; International Society for Aerosols in Medicine What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331. PubMed

Leung J, Bhutani M, Leigh R, Pelletier D, Good C, Sin DD. Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma. Can Respir J. 2015;22(5):266–270. PubMed PMC

Haroon S, Jordan R, Takwoingi Y, Adab P. Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis. BMJ Open. 2015;5(10):e008133. PubMed PMC

Pietinalho A, Kinnula V, Sovijärvi A, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med. 2007;101(7):1419–1425. PubMed

Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116:416–423. PubMed

Zwar NA, Marks GB, Hermiz O, et al. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust. 2011;195(4):168–171. PubMed

Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673–678. PubMed PMC

Roberts CM, Abedi MKA, Barry JS, et al. Predictive value of primary care made clinical diagnosis of chronic obstructive pulmonary disease (COPD) with secondary care specialist diagnosis based on spirometry performed in a lung function laboratory. Prim Health Care Res Dev. 2009;10:49.

Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402–407. PubMed